To our knowledge, no prior study has concurrently tracked VEGF, PDGF-AB, EGF, and TGF-β kinetics alongside clinical outcomes (pain, function, tendon thickness) over 3 months post-PRP versus saline in tenosynovitis with a sufficiently large cohort to ensure robust generalizability. The gene discussed is EGF; the disease is tenosynovitis.